Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Vitamin D, carotid intima-media thickness, and bone structure in patients with type 2 diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Mitochondrial mutation m.3243A>G associates with insulin resistance in non-diabetic carriers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Cross-sectional analysis of sleep hours and quality with sex hormones in men

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence and prevalence of sporadic and hereditary MTC in Denmark 1960-2014: a nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Semen quality in patients with pituitary disease and adult-onset hypogonadotropic hypogonadism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Metformin monotherapy for adults with type 2 diabetes mellitus (Protocol)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prediction of Excessive Weight Gain in Insulin Treated Patients with Type 2 Diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Karoline Winckler
  • Lise Tarnow
  • Louise Lundby Christensen
  • Thomas Peter Almdal
  • Niels Wiinberg
  • Pia Eiken
  • Trine Welløv Boesgaard
  • CIMT trial group (Bianca Hemmingsen, member)
Vis graf over relationer

Despite aggressive treatment of cardiovascular disease (CVD) risk factors individuals with type 2 diabetes (T2D) still have increased risk of cardiovascular morbidity and mortality. The primary aim of this study was to examine the cross-sectional association between total (25(OH)D) and risk of CVD in patients with T2D. Secondary objective was to examine the association between 25(OH)D and bone health. A Danish cohort of patients with T2D participating in a randomised clinical trial were analysed. In total 415 patients (68 % men, age 60±9 years (mean±SD), duration of diabetes 12±6 years), including 294 patients (71%) treated with insulin. Carotid intima-media thickness (IMT) and arterial stiffness (carotid artery distensibility coefficient (DC) and Young's elastic modulus (YEM)) were measured by ultrasound scan as indicators of CVD. Bone health was assessed by bone mineral density (BMD) and trabecular bone score (TBS) measured by Dual energy X-ray absorptiometry (DXA). In this cohort, 214 patients (52 %) were vitamin D deficient (25(OH)D < 50 nmol/l). Carotid IMT was 0.793±0.137 mm, DC was 0.0030±0.001 mmHg-1, YEM was 2354±1038 mmHg and 13 (3%) of the patients were diagnosed with osteoporosis. 25(OH)D level was not associated with carotid IMT or arterial stiffness (P > 0.3) or bone health (P > 0.6) after adjustment for CVD risk factors. In conclusion, 25(OH)D status was not associated with carotid IMT, arterial stiffness or bone health in this cohort of patients with T2D. To explore these associations and the association with other biomarkers further, multicentre studies with large numbers of patients are required.

OriginalsprogEngelsk
TidsskriftEndocrine Connections
Vol/bind4
Udgave nummer2
Sider (fra-til)128-135
ISSN2049-3614
DOI
StatusUdgivet - 8 maj 2015

ID: 45347424